275 related articles for article (PubMed ID: 26798348)
21. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
[TBL] [Abstract][Full Text] [Related]
22. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report.
Goto Y; Furuno Y; Kawabe T; Ohwada K; Tatsuzawa K; Sasajima H; Hashimoto N
J Neurosurg; 2017 Feb; 126(2):431-434. PubMed ID: 27177173
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of denosumab in the treatment of pulmonary metastatic giant cell tumor of bone.
Luo Y; Tang F; Wang Y; Zhou Y; Min L; Zhang W; Shi R; Duan H; Tu C
Cancer Manag Res; 2018; 10():1901-1906. PubMed ID: 30013396
[TBL] [Abstract][Full Text] [Related]
24. Giant Cell Tumor Developing in Paget's Disease of Bone: A Case Report with Review of Literature.
Verma V; Puri A; Shah S; Rekhi B; Gulia A
J Orthop Case Rep; 2016; 6(4):103-107. PubMed ID: 28164066
[TBL] [Abstract][Full Text] [Related]
25. [Treatment progress on giant cell tumors of bone].
Liang P
Zhongguo Gu Shang; 2018 Mar; 31(3):292-296. PubMed ID: 29600686
[TBL] [Abstract][Full Text] [Related]
26. Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone.
Gaston CL; Grimer RJ; Parry M; Stacchiotti S; Dei Tos AP; Gelderblom H; Ferrari S; Baldi GG; Jones RL; Chawla S; Casali P; LeCesne A; Blay JY; Dijkstra SP; Thomas DM; Rutkowski P
Clin Sarcoma Res; 2016; 6(1):15. PubMed ID: 27651889
[TBL] [Abstract][Full Text] [Related]
27. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
Chawla S; Blay JY; Rutkowski P; Le Cesne A; Reichardt P; Gelderblom H; Grimer RJ; Choy E; Skubitz K; Seeger L; Schuetze SM; Henshaw R; Dai T; Jandial D; Palmerini E
Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134
[TBL] [Abstract][Full Text] [Related]
28. Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Clival Giant Cell Tumor: A Case Report and Review of the Literature.
Inoue A; Ohnishi T; Kohno S; Nishikawa M; Nishida N; Ohue S
World Neurosurg; 2016 Jul; 91():674.e1-6. PubMed ID: 27113403
[TBL] [Abstract][Full Text] [Related]
29. Combining of serial embolization and denosumab for large sacropelvic giant cell tumor: Case report of 3 cases.
Ji T; Yang Y; Wang Y; Sun K; Guo W
Medicine (Baltimore); 2017 Aug; 96(33):e7799. PubMed ID: 28816971
[TBL] [Abstract][Full Text] [Related]
30. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
[TBL] [Abstract][Full Text] [Related]
31. RANKL, denosumab, and giant cell tumor of bone.
Thomas DM
Curr Opin Oncol; 2012 Jul; 24(4):397-403. PubMed ID: 22581354
[TBL] [Abstract][Full Text] [Related]
32. Denosumab Treatment for a Residual Giant Cell Tumor of the Clivus: A Case Report and Review of the Literature.
Huh A; Villelli N; Martinez D; Ting J; Birhiray R; Payner TD; Kulwin CG
World Neurosurg; 2018 Oct; 118():98-101. PubMed ID: 30010069
[TBL] [Abstract][Full Text] [Related]
33. The dilemma of denosumab: Salvage of a femoral head giant cell tumour.
Gaston CL; Puls F; Grimer RJ
Int J Surg Case Rep; 2014; 5(11):783-6. PubMed ID: 25290381
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
Lau CP; Huang L; Wong KC; Kumta SM
Connect Tissue Res; 2013; 54(6):439-49. PubMed ID: 24060052
[TBL] [Abstract][Full Text] [Related]
35. Giant cell tumors of the spine: has denosumab changed the treatment paradigm?
Goldschlager T; Dea N; Boyd M; Reynolds J; Patel S; Rhines LD; Mendel E; Pacheco M; Ramos E; Mattei TA; Fisher CG
J Neurosurg Spine; 2015 May; 22(5):526-33. PubMed ID: 25700239
[TBL] [Abstract][Full Text] [Related]
36. How safe and effective is denosumab for bone giant cell tumour?
Errani C; Tsukamoto S; Mavrogenis AF
Int Orthop; 2017 Nov; 41(11):2397-2400. PubMed ID: 28646421
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Denosumab and Risk Factors for Recurrence in Spinal Giant Cell Tumors: A Systematic Review and Meta-Analysis.
Noh SH; Ha Y; Cho PG; Kim KN; Shin DA; Kim SH
Yonsei Med J; 2022 Sep; 63(9):834-841. PubMed ID: 36031783
[TBL] [Abstract][Full Text] [Related]
38. Successful Intravascular Correction of Intratumoral Pseudoaneurysm by Erosion of the Aorta in a Patient with Thoracic Giant Cell Tumor of Bone Responding to Denosumab.
Fraile NM; Toloi D; Kurimori CO; Matutino AR; Codima A; Camargo VP; Feher O; Munhoz RR
Case Rep Oncol Med; 2015; 2015():626741. PubMed ID: 26600960
[TBL] [Abstract][Full Text] [Related]
39. Denosumab for Treatment of a Recurrent Cervical Giant-Cell Tumor.
Kajiwara D; Kamoda H; Yonemoto T; Iwata S; Ishii T; Tsukanishi T; Ohtori S; Yamazaki M; Okawa A
Asian Spine J; 2016 Jun; 10(3):553-7. PubMed ID: 27340537
[TBL] [Abstract][Full Text] [Related]
40. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
